At TALOX we use a proprietary AI trained on patient data to decode oncology drug resistance and create new therapies. Welcome to the pinnacle of techbio innovation, where cutting-edge research meets unparalleled expertise. Our commitment to excellence fuels the discovery of transformative solutions that redefine the possibilities in oncology healthcare and beyond.